WJ, B., A, P., KC, H., & AI, Y. (2021). Discordance between day-3 follicle stimulating hormone & anti-Müllerian hormone is predictive of clinical pregnancy during fertility treatment. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 37(9), 798. https://doi.org/10.1080/09513590.2020.1862788
Chicago Style (17th ed.) CitationWJ, Butler, Pico A, Hawkins KC, and Younis AI. "Discordance Between Day-3 Follicle Stimulating Hormone & Anti-Müllerian Hormone Is Predictive of Clinical Pregnancy During Fertility Treatment." Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology 37, no. 9 (2021): 798. https://doi.org/10.1080/09513590.2020.1862788.
MLA (9th ed.) CitationWJ, Butler, et al. "Discordance Between Day-3 Follicle Stimulating Hormone & Anti-Müllerian Hormone Is Predictive of Clinical Pregnancy During Fertility Treatment." Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology, vol. 37, no. 9, 2021, p. 798, https://doi.org/10.1080/09513590.2020.1862788.